A detailed history of Umpqua Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Umpqua Bank holds 2,352 shares of ABBV stock, worth $418,679. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,352
Previous 2,210 6.43%
Holding current value
$418,679
Previous $379 Million 22.53%
% of portfolio
0.17%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$163.84 - $199.33 $23,265 - $28,304
142 Added 6.43%
2,352 $464 Million
Q2 2024

Aug 06, 2024

BUY
$154.79 - $180.76 $67,024 - $78,269
433 Added 24.37%
2,210 $379 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $284,000 - $323,591
1,777 New
1,777 $324 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Umpqua Bank Portfolio

Follow Umpqua Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umpqua Bank, based on Form 13F filings with the SEC.

News

Stay updated on Umpqua Bank with notifications on news.